lorazepam has been researched along with Psychoses, Drug in 22 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Excerpt | Relevance | Reference |
---|---|---|
"A 53-year-old man with a 3-month addiction to approximately 5 mg/day of triazolam experienced psychosis and delirium following relatively abrupt withdrawal from the drug." | 7.67 | A case of psychosis and delirium following withdrawal from triazolam. ( Capwell, R; Heritch, AJ; Roy-Byrne, PP, 1987) |
"A 53-year-old man with a 3-month addiction to approximately 5 mg/day of triazolam experienced psychosis and delirium following relatively abrupt withdrawal from the drug." | 3.67 | A case of psychosis and delirium following withdrawal from triazolam. ( Capwell, R; Heritch, AJ; Roy-Byrne, PP, 1987) |
" Lorazepam is more likely to require repeat dosing than droperidol." | 2.68 | Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone. ( Derlet, RW; Duncan, DR; Richards, JR, 1997) |
"A 24-year old woman with multisubstance use since the age of 13, including opioids and cocaine, and long-standing HIV/HCV seropositivity status, presented with psychosis, agitation, and insomnia at the emergency department of a university hospital." | 1.43 | Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths. ( Calabrò, G; Caloro, M; Corkery, JM; Cuomo, I; De Filippis, S; de Pisa, E; Di Tommaso, A; Girardi, P; Kotzalidis, GD; Lionetto, L; Locatelli, CA; Lonati, D; Ranieri, V; Schifano, F; Vento, AE, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (13.64) | 18.7374 |
1990's | 8 (36.36) | 18.2507 |
2000's | 5 (22.73) | 29.6817 |
2010's | 6 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leandre, F | 1 |
Ginory, A | 1 |
West, S | 1 |
Kenedi, C | 1 |
Smith, DL | 1 |
Roberts, C | 1 |
Mohapatra, S | 1 |
Sahoo, AJ | 1 |
Caloro, M | 1 |
Calabrò, G | 1 |
Kotzalidis, GD | 1 |
Cuomo, I | 1 |
Corkery, JM | 1 |
Vento, AE | 1 |
Lionetto, L | 1 |
De Filippis, S | 1 |
Ranieri, V | 1 |
Lonati, D | 1 |
Locatelli, CA | 1 |
de Pisa, E | 1 |
Di Tommaso, A | 1 |
Girardi, P | 1 |
Schifano, F | 1 |
Peterson, E | 1 |
Stoebner, A | 1 |
Weatherill, J | 1 |
Kutscher, E | 1 |
Bansal, V | 1 |
Kumar, S | 1 |
Mowar, A | 1 |
Sharma, S | 1 |
Gupta, S | 1 |
Thornton, SL | 1 |
Gerona, RR | 1 |
Tomaszewski, CA | 1 |
Rosenberg, MH | 1 |
Deerfield, LJ | 1 |
Baruch, EM | 1 |
Sinha, PK | 1 |
Ambesh, SP | 1 |
Hartsell, Z | 1 |
Drost, J | 1 |
Wilkens, JA | 1 |
Budavari, AI | 1 |
Marcus, A | 2 |
Ammermann, C | 1 |
Bahro, M | 2 |
Schmidt, MH | 2 |
Silva, RG | 1 |
Tolstunov, L | 1 |
Shenoy, RS | 1 |
Wodarz, N | 1 |
Böning, J | 1 |
Sartoris, J | 1 |
Galen, DM | 1 |
Beck, M | 1 |
Buchbinder, D | 1 |
Richards, JR | 1 |
Derlet, RW | 1 |
Duncan, DR | 1 |
Fisman, M | 1 |
Heritch, AJ | 1 |
Capwell, R | 1 |
Roy-Byrne, PP | 1 |
Carr, AC | 1 |
Fraser, AA | 1 |
Ingram, IM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effect of Steroid on Reducing Facial Swelling After Orthognathic Surgery[NCT01431014] | Phase 4 | 56 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
Prospective Evaluation of Perioperative Steroid Dosing on Postsurgical Edema in Orthognathic Surgery[NCT03190642] | Phase 4 | 180 participants (Actual) | Interventional | 2018-01-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Measure of facial swelling will be performed using 3-dimensional photogrammetry. The 3d photo acquisition is non-invasive without radiation concern. The images will be taken before and after surgery to measure and compare the degree of facial swelling. Side effects from the steroid use are expected to be low under normal clinical dosage, but will also be monitored. Symptoms of wound infection, psychosis, and prolonged wound healing will be studied. There should be no long term complication, since the steroid use is one single dose. (NCT01431014)
Timeframe: 1 year
Intervention | ml (Mean) | ||
---|---|---|---|
36 hours postoperatively | 1week postoperatively | 1month postoperatively | |
"DexamethasoneHigh-dose" | 167.06 | 61.39 | 29.85 |
"DexamethasoneLow-dose" | 190.73 | 57.62 | 19.34 |
2 reviews available for lorazepam and Psychoses, Drug
Article | Year |
---|---|
Strategies to prevent the neuropsychiatric side-effects of corticosteroids: a case report and review of the literature.
Topics: Adult; Amines; Benzodiazepines; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gaba | 2014 |
Managing alcohol withdrawal in hospitalized patients.
Topics: Alcohol-Induced Disorders; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Hospitalization; Humans; | 2007 |
1 trial available for lorazepam and Psychoses, Drug
Article | Year |
---|---|
Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone.
Topics: Adult; Central Nervous System Stimulants; Conscious Sedation; Droperidol; Emergencies; Female; Hemod | 1997 |
19 other studies available for lorazepam and Psychoses, Drug
Article | Year |
---|---|
A case of Baclofen withdrawal induced psychosis treated with lorazepam.
Topics: Anti-Anxiety Agents; Baclofen; GABA-B Receptor Agonists; Humans; Lorazepam; Male; Middle Aged; Psych | 2019 |
Synthetic marijuana use and development of catatonia in a 17-year-old male.
Topics: Adolescent; Cannabinoids; Cannabis; Catatonia; Designer Drugs; Electroconvulsive Therapy; Humans; Il | 2014 |
Drug-Induced Psychosis Associated with Albendazole-Ivermectin Combination Therapy in a 10-Year-Old Child.
Topics: Albendazole; Anti-Anxiety Agents; Antiparasitic Agents; Child; Drug Therapy, Combination; Humans; Iv | 2015 |
Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths.
Topics: Adult; Anti-Anxiety Agents; Anti-Retroviral Agents; Antipsychotic Agents; Female; Glycine; HIV Infec | 2016 |
Case of acute psychosis from herbal supplements.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dietary Supplements; Female; Haloperidol; Humans; Loraze | 2008 |
Postoperative psychosis in an adolescent subsequent to oral surgical outpatient procedure.
Topics: Antipsychotic Agents; Dexamethasone; Female; Glucocorticoids; Humans; Injections, Intravenous; Loraz | 2009 |
Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification.
Topics: Alkaloids; Benzodioxoles; Designer Drugs; Droperidol; Humans; Insufflation; Lorazepam; Male; Propiop | 2012 |
Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management.
Topics: Adult; Anticonvulsants; Antihypertensive Agents; Clonazepam; Clonidine; Delirium; Hospitalization; H | 2003 |
Pre-operative psychosis following oral lorazepam.
Topics: Acute Disease; Aged; Anti-Anxiety Agents; Humans; Lorazepam; Male; Premedication; Psychoses, Substan | 2003 |
Benzodiazepine administration induces exogenic psychosis: a case of child abuse.
Topics: Aggression; Anti-Anxiety Agents; Benzodiazepines; Child; Child Abuse; Child Welfare; Humans; Lorazep | 1995 |
Steroid-induced psychosis: report of case.
Topics: Dexamethasone; Edema; Haloperidol; Humans; Lorazepam; Male; Maxilla; Middle Aged; Osteotomy; Perphen | 1995 |
Pitfalls in the treatment of jimsonweed intoxication.
Topics: Adolescent; Contraindications; Datura stramonium; Drug Therapy, Combination; Haloperidol; Humans; Lo | 1994 |
["Ecstasy"-induced psychotic depersonalization syndrome].
Topics: 3,4-Methylenedioxyamphetamine; Adult; Combined Modality Therapy; Depersonalization; Designer Drugs; | 1993 |
Acute exogenic psychosis following oral ingestion of 2 mg lormetazepam in an eleven-year-old boy.
Topics: Adolescent; Animals; Anti-Anxiety Agents; Benzodiazepines; Child; Electroencephalography; Guinea Pig | 1993 |
Steroid psychosis after orthognathic surgery: a case report.
Topics: Adult; Anti-Inflammatory Agents; Antipsychotic Agents; Delirium; Delusions; Dexamethasone; Haloperid | 1997 |
Steroid psychosis after orthognathic surgery: a case report.
Topics: Adult; Anti-Inflammatory Agents; Antipsychotic Agents; Delirium; Delusions; Dexamethasone; Haloperid | 1997 |
Steroid psychosis after orthognathic surgery: a case report.
Topics: Adult; Anti-Inflammatory Agents; Antipsychotic Agents; Delirium; Delusions; Dexamethasone; Haloperid | 1997 |
Steroid psychosis after orthognathic surgery: a case report.
Topics: Adult; Anti-Inflammatory Agents; Antipsychotic Agents; Delirium; Delusions; Dexamethasone; Haloperid | 1997 |
Musical hallucinations: report of two unusual cases.
Topics: Aged; Aged, 80 and over; Deafness; Dementia; Female; Hallucinations; Humans; Lorazepam; Music; Presb | 1991 |
A case of psychosis and delirium following withdrawal from triazolam.
Topics: Delirium; Humans; Lorazepam; Male; Middle Aged; Psychoses, Substance-Induced; Substance Withdrawal S | 1987 |
Lorazepam dependence and chronic psychosis.
Topics: Humans; Lorazepam; Male; Psychoses, Substance-Induced; Substance-Related Disorders | 1986 |
Lorazepam dependence and chronic psychosis.
Topics: Adult; Diagnosis, Differential; Humans; Lorazepam; Male; Psychoses, Substance-Induced; Schizophrenia | 1985 |